Sách chuyên ngành Y Dược học: Atlas of Dermatology in Internal Medicine (Tập bản đồ về Y học da liễu)

NÉSTOR P. SÁNCHEZ

ATLAS OF DERMATOLOGY IN INTERNAL MEDICINE

(TẬP BẢN ĐỒ VỀ Y HỌC DA LIỄU)

PUBLISHER: SPRINGER (2012)

THÔNG TIN CHUNG:

Tên sách: Atlas of Dermatology in Internal Medicine (tạm dịch: Tập bản đồ về Y học da liễu).

Tác giả: Néstor P. Sánchez.

NXB: Springer (2012).

Thông số: 163 trang; 9 chương chính.

Các bệnh về da liễu là những chứng bệnh thường không gây ảnh hưởng quá lớn tới sức khỏe của con người, tuy nhiên tác động của chúng tới thẩm mỹ cũng như cuộc sống sinh hoạt hàng ngày là không thể phủ nhận. Cuốn atlas này sẽ cung cấp cho độc giả những kiến thức, hiểu biết tiến bộ và chuyên sâu nhất về chuyên ngành Y học da liễu, từ các bệnh thường gặp cho tới bệnh da liễu nguy hiểm, cách chẩn đoán và phương pháp điều trị....

INTRODUCTION (GIỚI THIỆU):

Dermatology is a fascinating fi eld based in the skills of clinical observation and clinicopatho- logic correlation to diagnose diseases. We wish to bring the art and science of dermatology into a practical resource. In this spirit, we created Atlas of Dermatology in Internal Medicine. Skin refl ects the health of the body and its diseases are often a manifestation of systemic conditions. To know skin disorders is of paramount importance for other specialties. We are committed to creating an excellent tool to assist in the diagnosis and management of common cutaneous manifestations of systemic diseases. Atlas of Dermatology in Internal Medicine is organized to refl ect current knowledge in dermatology relevant to Internal Medicine. It provides a comprehensive review and updated information on the diagnosis and treatment of common cutaneous manifestations of systemic diseases. To facilitate the diagnosis of frequently encountered skin diseases, a gallery of illus- trations combined with disease descriptions and their current therapeutic information are included. This book welcomes internists and other specialists in medicine interested in learn- ing more about clinical dermatology. We are proud to present our work. We hope this text will provide a timely addition to the fi eld of Internal Medicine. We would like to thank the authors who contributed in this book.

TABLE OF CONTENTS (MỤC LỤC):

Cutaneous Manifestations of Connective Tissue Diseases

Cutaneous Manifestations of Pulmonary Disease

Cutaneous Manifestations of Renal Disease

Cutaneous Manifestations of Gastrointestinal Diseases

Cutaneous Manifestations of Common Endocrine Disease

Cutaneous Manifestations of Internal Malignancy and Paraneoplastic Syndromes

Cutaneous Manifestations of Infectious Diseases

Cutaneous Manifestations of HIV Disease

Cutaneous Disorders in the Intensive Care Unit

Index

REFERENCES (TÀI LIỆU THAM KHẢO):

1. Sontheimer RD. Dermatomyositis: An overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002; 20: 387–408.

2. Ostezan LB, Callen JP. Cutaneous manifestations of selected rheu-matologic diseases. Am Fam Physician. 1996; 53: 1625–36.

3. Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus ery-thematosus: Diagnosis and management. Am J Clin Dermatol. 2003; 4: 449–65.

4. Laman SD, Provost TT. Cutaneous manifestations of lupus erythe-matosus. Rheum Dis Clin North Am. 1994; 20: 195–212.

5. Akbarian M, Faezi ST, Gharibdoost F, et al. Systemic lupus erythe-matosus in Iran: A study of 2280 patients over 33 years. Int J Rheum Dis. 2010; 13: 374–9.

6. Farley-Loftus R, Elmariah SB, Ralston J, et al. Hypertrophic discoid lupus erythematosus. Dermatol Online J. 2010; 16: 1.

7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classifi cation of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–7.

8. Kuhn A, Gensch K, Haust M, et al. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: A randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol. 2011; 64: 37–48.

9. Mastalgia FL, Garlepp MJ, Phillips BA, Zilko PJ. Infl ammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle Nerv. 2003; 27: 407–25.

10. Koler RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001; 64: 1565–72.

11. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Practical rheumatology. 3rd ed. London: Mosby; 2004.

12. Rider LG, Miller FW. Deciphering the clinical presentations, patho-genesis, and treatment of the idiopathic infl ammatory myopathies. JAMA. 2011; 305: 183–90.

13. Distad BJ, Amato AA, Weiss MD. Infl ammatory myopathies. Curr Treat Options Neurol. 2011; 13 (2): 119–30.

14. Olsen NJ. Scleroderma: The need for extreme remedies. Am J Med Sci. 2011. (Epub ahead of print).

15. Black CM. Scleroderma, clinical aspects. J Intern Med. 1993; 234: 115–8.

16. Hassoun PM. Lung involvement in systemic sclerosis. Presse Med. 2011; 40 (1 Pt 2): E3–17.

17. Masi AT, Rodnan GP, et al. Preliminary criteria for the classifi ca-tion of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581–90.

18. Clements PJ. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. P. 129–35.

19. Mahoney Jr WM, Fleming JN, Schwartz SM. A unifying hypothe-sis for scleroderma: Identifying a target cell for scleroderma. Curr Rheumatol Rep. 2011; 13: 28–36.

20. Sehgal VN, Srivastava G, et al. Localized scleroderma/morphea. In J Dermatol. 2002; 41: 467–75.

21. Nakamura T, Higashi S, Tomoda K, et al. Cutaneous nodules in patients with rheumatoid arthritis: A case report and review of litera-tures. Clin Rheumatol. 2011; 30 (5): 719–22.

22. Lee DM, Weinblatt ME. Rheumatoid arthritis [comment]. Lancet. 2001; 358: 903–11.

23. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27: 269–81.

24. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology. 2002; 41: 793–800.

25. Sayah A, English JC. Rheumatoid arthritis: A review of the cutane-ous manifestations. J Am Acad Dermatol. 2005; 53: 191–209.

26. Ergun T, Inanc N, Tuney D, Kotiloglu EK, Seckin D, Direskeneli H. Skin manifestations of rheumatoid arthritis: A study of 215 Turkish patients. Int J Dermatol. 2008; 47 (9): 894–902.

27. Ruddy S, Harris ED, Sledge CB. Kelley’s textbook of rheumatol-ogy. 6th ed. Philadelphia: WB Saunders; 2001.

28. Jorizzo JL, Gonzalez EB, Daniels JC. Red lunulae in a patient with rheumatoid arthritis. J Am Acad Dermatol. 1983; 8: 711–4.

29. Ziff M. The Rheumatoid nodule. Arthritis Rheum. 1990; 33: 761–7.

30. Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis. A clinical and pathological study of 43 patients. J Cutan Pathol. 2003; 30: 1–10.

31. Young A, Koduri G. Extra-articular manifestations and complica-tions of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007; 21 (5): 907–27.

32. Kaye BR, Kaye RL, Bobrove A. Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new clas-sifi cation, with a report of four seronegative cases. Am J Med. 1984; 76: 279–92.

33. Ahmed SS, Arnett FC, Smith CA, et al. The HLA-DRB1* 0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: A follow-up study of 79 Caucasian patients with rheumatoid arthritis. Medicine. 2001; 80: 271–8.

34. Lems WF, Dijkmans BA. Rheumatoid arthritis: Clinical picture and its variants. In: Firestein GS, Panayi GS, Wollheim FA, editors. Rheumatoid arthritis: Frontiers in pathogenesis and treatment. New York: Oxford University Press; 2000. P. 219.

35. Higaki Y, Kim KJ, Kawashima M. Rheumatoid nodules on the dis-tal region of the sole. J Dermatol. 1997; 24: 798.

36. Appleton MA, Ismail SM. Ulcerating rheumatoid nodule of the vulva. J Clin Pathol. 1996; 49: 85–7.

37. Sokoloff L, McCluskey RT, Bunim JJ. Vascularity of the early sub-cutaneous nodules of RA. Arch Pathol. 1953; 55: 475–95.

38. Aherne MJ, Bacon PA, Blake DR, et al. Immunohistochemical fi ndings in rheumatoid nodules. Virchows Arch A Pathol Anat Histopathol. 1985; 407: 191–202.

39. Miyasaka N, Sato K, Yamamoto K, et al. Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis. 1989; 48: 220–6.

40. Palmer DG, Hogg N, Highton J, et al. Macrophage migration and maturation within rheumatoid nodules. Arthritis Rheum. 1987; 30: 728–36.

41. Hessian P, Highton J, Kean A, et al. Cytokine profi le of the rheuma-toid nodule suggests that it is a Th1 granuloma. Arthritis Rheum. 2003; 48: 334–8.

42. Gall EP. General features. In: Schumacher HR, Gall EP, editors. Rheumatoid arthritis: An illustrated guide to pathology, diagnosis, and management, vol. 1. Philadelphia: JB Lippincott; 1988. P. 28.

43. Sibbitt WL, Williams RC. Cutaneous manifestations of rheumatoid arthritis. Int J Dermatol. 1982; 21: 563–72.

44. Kremer JM, Lee JK. The safety and effi cacy of the use of metho-trexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum. 1986; 29: 822–31.

45. Segal R, Caspi D, Tishler M, et al. Accelerated nodulosis and vas-culitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1988; 31: 1182–5.

46. Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002; 47: 445–9.

47. Kekow J, Welte T, Kellner U, et al. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etan-ercept. Arthritis Rheum. 2002; 46: 843–4.

48. Kernstens PJ, Boerbooms AM, Jeurissen ME, Fast JH, Assmann KJ, van de Putte LB. Accelerated nodulosis during low dose metho-trexate therapy for rheumatoid arthritis. An analysis of ten cases [comment]. J Rheumatol. 1992; 19: 867–71.

49. Garcia-Patos V. Rheumatoid nodule. Semin Cutan Med Surg. 2007; 26: 100–7.

50. Bywaters EG. A variant of rheumatoid arthritis characterized by recurrent digital pad nodules and palmar fasciitis, closely resem-bling palindromic rheumatism. Ann Rheum Dis. 1949; 8: 2–30.

51. Ginsberg MH, Genant HK, Yu TF, et al. Rheumatoid nodulosis: An unusual variant of rheumatoid arthritis. Arthritis Rheum. 1975; 18: 49–58.

52. Couret M, Combe B, Chuong VT, et al. Rheumatoid nodulosis: Report of two new cases and discussion of diagnostic criteria. J Rheumatol. 1988; 15: 1427–30.

53. Toussirot E, Tiberghien P, Balblanc JC, Kremer P, Despaux J, Dupond JL, et al. HLA DRB1* Alleles in rheumatoid nodulosis: A comparative study with rheumatoid arthritis with and without nodules. Rheumatol Int. 1998; 17: 233–6.

54. Kai Y, Anzai S, Shibuya H, et al. A case of rheumatoid nodulosis successfully treated with surgery. J Dermatol. 2004; 31: 910–5.

55. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the development of vasculitis in rheumatoid arthritis: Results of a case-control study. Ann Rheum Dis. 1996; 55: 190–2.

56. Watts RA, Carruthers DM, Symmons DP, Scott DG. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol. 1994; 33: 832–3.

57. Tuveri M, Genenni S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet. 2000; 356: 1739–40.

58. Sommer S, Sheehan-Dare RA. Atrophie blanche-like scarring after pulsed dye laser treatment. J Am Acad Dermatol. 1999; 41 (1): 100–2.

59. Chen KR, Toyohara A, Suzuki A, Miyakawa S. Clinical and histo-pathological spectrum of cutaneous vasculitis in rheumatoid arthri-tis. Br J Dermatol. 2002; 147: 903–13.

60. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: A review. Semin Arthritis Rheum. 2006; 36 (2): 88–98.

61. Scott DG, Bacon PA. Intravenous cyclophosphamide plus methyl-prednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984; 76: 377–84.

62. Chen KR, Toyohara A, Suzuki A, Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol. 2002; 147 (5): 905–13.

63. Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological fea-tures of severe vasculitis in rheumatoid arthritis: Prognostic impli-cations. Ann Rheum Dis. 1987; 46: 727–33.

64. O’Gradaugh D, Watts RA, Scott DG. Extra-articular features of rheumatoid arthritis. In: Firestein GS, Panayi GS, Wollheim FA, editors. Rheumatoid arthritis: Frontiers in pathogenesis and treat-ment. New York: Oxford University Press; 2000. P. 229–32.

65. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: Classifi ca-tion and management. J Am Acad Dermatol. 1996; 34: 395–409.

66. Von den Driesh P. Pyoderma gangrenosum: A report of 44 cases with follow-up. Br J Dermatol. 1997; 137: 1000–5.

67. Hickman JG, Lazarus GS. Pyoderma gangrenosum: A reappraisal of associated systemic diseases. Br J Dermatol. 1980; 102: 235–7.

68. Holt PJ, Davies MG, Saunders KC, Nuki G. Pyoderma gangreno-sum: Clinical and laboratory fi ndings in 15 patients with special reference to polyarthritis. Medicine. 1980; 59: 114–33.

69. Reynolds NJ, Peachey RD. Response of atypical bullous pyoderma gangrenosum to oral monocycline, hydrochloride, and topical steroids. Acta Derm Venereol. 1990; 70: 538–9.

70. Dykman CJ, Galens GJ, Good AE. Linear subcutaneous bands in rheumatoid arthritis: An unusual form of rheumatoid granuloma. Ann Intern Med. 1965; 63: 134–40.

71. Ackerman AB, White WL, Guo Y. Differential diagnosis in dermatopathology, vol. 4. Philadelphia: Lea & Febiger; 1994. P. 34–7.

72. Long D, Thiboutot DM, Majeski JT, Vasily DB, Helm KF. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol. 1996; 34: 957–61.

73. Vemeuil L, Dompmartin A, Comoz F, Pasquier CJ, Leroy D. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: A disorder associated with autoantibodies. J Am Acad Dermatol. 2001; 45: 286–91.

74. Wollina U, Schoniebe J, Unger L, Weigel K, Kostler E, Nusslein H. Interstitial granulomatous dermatitis with plaques and arthritis. Clin Rheumatol. 2003; 22: 347–9.

75. Magro CM, Crowson AN, Schapiro BL. The interstitial granuloma-tous drug reaction: A distinctive clinical and pathological entity. J Cutan Pathol. 1998; 25: 72–8.

76. Sangueza OP, Caudell MD, Mengesha TM, Davis LS, Barnes CJ, Griffen JE, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002; 47: 251–7.

77. Scherbenske JM, Benson PM, Lupton GP, Samlaska CP. Rheumatoid neutrophilic dermatitis. Arch Dermatol. 1989; 125: 1105–8.

78. Brown TS, Fearyhough PK, Burruss JB, Callen JP. Rheumatoid neutrophilic dermatitis in a woman with sero-negative rheumatoid arthritis. J Am Acad Dermatol. 2001; 45: 596–600.

Download Ebook: TLAS OF DERMATOLOGY IN INTERNAL MEDICINE

========================